| The NLRP3 inflammasome is activated by nanoparticles through ATP, ADP and adenosine L Baron, A Gombault, M Fanny, B Villeret, F Savigny, N Guillou, C Panek, ... Cell death & disease 6 (2), e1629-e1629, 2015 | 208 | 2015 |
| B cell activating factor is central to bleomycin-and IL-17-mediated experimental pulmonary fibrosis A François, A Gombault, B Villeret, G Alsaleh, M Fanny, P Gasse, ... Journal of autoimmunity 56, 1-11, 2015 | 108 | 2015 |
| Regulatory T cell-derived TGF-β1 controls multiple checkpoints governing allergy and autoimmunity JA Turner, E Stephen-Victor, S Wang, MN Rivas, A Abdel-Gadir, H Harb, ... Immunity 53 (6), 1202-1214. e6, 2020 | 105 | 2020 |
| The IL-33 receptor ST2 regulates pulmonary inflammation and fibrosis to bleomycin M Fanny, M Nascimento, L Baron, C Schricke, I Maillet, M Akbal, N Riteau, ... Frontiers in immunology 9, 1476, 2018 | 35 | 2018 |
| Tissue-specific expression of the low-affinity IgG receptor, FcγRIIb, on human mast cells OT Burton, A Epp, ME Fanny, SJ Miller, AJ Stranks, JE Teague, RA Clark, ... Frontiers in immunology 9, 1244, 2018 | 35 | 2018 |
| B-cell activating factor secreted by neutrophils is a critical player in lung inflammation to cigarette smoke exposure M Nascimento, S Huot-Marchand, A Gombault, C Panek, M Bourinet, ... Frontiers in immunology 11, 1622, 2020 | 17 | 2020 |
| The NLRP3 inflammasome is activated by nanoparticles through ATP, ADP and adenosine. Cell Death Dis 6: e1629 L Baron, A Gombault, M Fanny, B Villeret, F Savigny, N Guillou, C Panek, ... | 13 | 2014 |
| Tumor-selective activity of XTX202, a protein-engineered IL-2, in mice without peripheral toxicities in nonhuman primates. J O'Neil, W Guzman, O Yerov, P Johnson, M Fanny, J Greene, ... Journal of Clinical Oncology 39 (15_suppl), 2563-2563, 2021 | 7 | 2021 |
| XTX301, A Protein-engineered IL-12, Exhibits Tumor-selective Activity In Mice Without Peripheral Toxicities And Is Well Tolerated In Non-Human Primates E Patel, N Malkova, S Vu, R O’Donnell, M Fanny, W Guzman, P Johnson, ... Journal for ImmunoTherapy of Cancer 9, A748-A748, 2021 | 2 | 2021 |
| B-cell activating factor regulates IL-1β-and IL-17A-mediated pulmonary fibrosis in mice M Fanny, A Gombault, F Francois, B Villeret, B Ryffel, D Wachhsmann, ... Revue des Maladies Respiratoires 32 (3), 311, 2015 | 2 | 2015 |
| XTX301, a Tumor-Activated Interleukin-12 Has the Potential to Widen the Therapeutic Index of IL12 Treatment for Solid Tumors as Evidenced by Preclinical Studies E Patel, NV Malkova, D Crowe, M Pederzoli-Ribeil, D Fantini, M Fanny, ... Molecular Cancer Therapeutics 23 (4), 421-435, 2024 | 1 | 2024 |
| NLRP6 controls pulmonary inflammation from cigarette smoke in a gut microbiota-dependent manner M Nascimento, S Huot-Marchand, M Fanny, M Straube, M Le Bert, ... Frontiers in Immunology 14, 1224383, 2023 | | 2023 |
| 1056 XTX301, a tumor activated, half-life extended IL-12 promoted potent anti-tumor immunity and activity across multiple syngeneic tumor models NV Malkova, E Patel, S Vu, D Fantini, M Fanny, W Guzman, S Hsiao, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| A half-life extended, tumor-activated IL-12 increased the infiltration of effector immune cells into the tumor microenvironment and demonstrated anti-tumor activity in … N Malkova, E Patel, S Vu, D Fantini, R O'Donnell, M Fanny, J Greene, ... Cancer Research 83 (7_Supplement), 587-587, 2023 | | 2023 |
| XTX202, a tumor-selective protein-engineered IL-2, exhibited enhanced anti-tumor activity in combination with checkpoint inhibition in mice W Guzman, HR Madala, H Duprey, M Fanny, J Greene, S Hsiao, ... Prostate 5, 80, 2022 | | 2022 |
| Etude des mécanismes de l’inflammation pulmonaire lors de l’exposition aux nanoparticules ou la fumée de cigarette: implication des voies de signalisations des récepteurs ST2 … M Fanny Université d'Orléans, 2016 | | 2016 |
| NLRP6 inflammasome is a critical player in pulmonary inflammation to cigarette smoke in mice A Gombault, M Fanny, C Panek, F Savigny, M Chamaillard, I Couillin Revue des Maladies Respiratoires 32 (3), 333, 2015 | | 2015 |
